DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Dec 19, 2024

Keywords

ClinConnect Summary

This clinical trial, called DAANCE for CHEMOTHERAPY-INDUCED NEUROPATHY, is looking at a new way to help breast cancer survivors who are dealing with nerve damage caused by chemotherapy. Many women who have survived breast cancer experience symptoms like tingling, numbness, and balance issues, which can affect their quality of life and increase the risk of falls. The study will explore a noninvasive treatment using Adapted Argentine Tango, a type of dance that aims to improve movement control and reduce symptoms, while also encouraging participants to engage in their own treatment.

To be eligible for this trial, participants should have been diagnosed with breast cancer (at any stage) and completed a specific type of chemotherapy at least three months ago. They should also be experiencing symptoms of nerve damage and have a balance score that suggests they might be at risk of falling. Participants will be asked to follow directions during the study, but they should be able to walk independently, even if they use assistive devices. The trial is currently recruiting, and it's a great opportunity for those looking to improve their symptoms and participate in a fun, social activity while receiving support.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Breast Cancer (BC) diagnosis of Stage I-IV including metastatic disease
• • completed taxane-based chemotherapy for BC at least 3 months ago (no limit on how long ago)
• • symptomatic for chemotherapy-induced neuropathy (self-report)
• • postural control score that indicates potential fall-risk
• • able to understand and comply with directions associated with testing and study treatments
• Exclusion Criteria:
• • pre-existing vestibular dysfunction
• • poorly controlled diabetes (hgA1C\>=8)
• • non-ambulatory (assistive and prosthetic devices allowed)
• • hearing impairment resulting in less than 10% hearing bilaterally
• • contraindication to participate in the experimental physical activity per the treating oncologist due to additional condition (e.g., herniated disc, unstable bone metastases)
• • currently in activity-based therapy (e.g., physical therapy, occupational therapy). May enroll if still meet eligibility criteria once activity-based therapy is complete.